Florentia Dimitriou (F Dimitriou, F Dimitrou)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Palliative Care

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Florentia Dimitriou, Phil Fang Cheng, Annalisa Saltari, Katrin Schaper-Gerhardt, Ramon Staeger, Veronika Haunerdinger, Federica Sella, Aizhan Tastanova, Christian Urban, Susanne Dettwiler, Daniela Mihic-Probst, Christian M Matter, Olivier Michielin, Ralf Gutzmer, Georgina V Long, Burkhard Becher, Mitchell Paul Levesque, Reinhard Dummer
A targetable type III immune response with increase of IL-17A expressing CD4 + T cells is associated with immunotherapy-induced toxicity in melanoma. Nature cancer (2024)
Alexander Troesch, Hoellwerth Magdalena, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F Cheng, Mitchell L Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Koelblinger Peter, Reinhard Dummer, Florentia Dimitriou
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centres. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Alexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F Cheng, Mitchell L Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas; a retrospective cohort study from five European skin cancer reference centers. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
E L Looman, Phil Fang Cheng, J Lai-Kwon, L Morgan, M Wakkee, R Dummer, Florentia Dimitriou
Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors. Cancer medicine (2023)
Michèle Welti, Florentia Dimitriou, Ralf Gutzmer, Reinhard Dummer
Triple Combination of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in BRAF V600 Melanoma: Current Status and Future Perspectives. Cancers 14 (22) (2022)
Genevieve Ho, Rodrigo J Schwartz, Amanda Regio Pereira, Florentia Dimitriou, E Paver, C McKenzie, R P M Saw, Richard A Scolyer, Georgina V Long, Richard A Scolyer
Reflectance confocal microscopy - a non-invasive tool for monitoring systemic treatment response in stage III unresectable primary scalp melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
E Papadavid, Eirini Kapniari, V Pappa, Vasiliki A Nikolaou, T Iliakis, Maria Dalamaga, C Jonak, S Porkert, S Engelina, Pietro Quaglino, Pablo Luis Ortiz-Romero, Cristina Vico-Alonso, A Cozzio, Florentia Dimitriou, R Guiron, Emmanuella Guenova, E Hodak, Martine Bagot, Julia J Scarisbrick
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity. The British journal of dermatology 185 (5) (2021)